CH666406A5 - Verfahren zur herstellung von mikrokapseln, welche bromokriptinmesylat als pharmakologischen wirkstoff enthalten. - Google Patents

Verfahren zur herstellung von mikrokapseln, welche bromokriptinmesylat als pharmakologischen wirkstoff enthalten. Download PDF

Info

Publication number
CH666406A5
CH666406A5 CH6660/83A CH666083A CH666406A5 CH 666406 A5 CH666406 A5 CH 666406A5 CH 6660/83 A CH6660/83 A CH 6660/83A CH 666083 A CH666083 A CH 666083A CH 666406 A5 CH666406 A5 CH 666406A5
Authority
CH
Switzerland
Prior art keywords
acid
weight
lactic acid
molecular weight
matrix
Prior art date
Application number
CH6660/83A
Other languages
German (de)
English (en)
Inventor
Joachim Dr Franz
Walter Dr Prikoszovich
Zdenek Dr Brich
Original Assignee
Sandoz Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz Ag filed Critical Sandoz Ag
Publication of CH666406A5 publication Critical patent/CH666406A5/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4866—Organic macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/48—Ergoline derivatives, e.g. lysergic acid, ergotamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
CH6660/83A 1984-02-29 1983-12-14 Verfahren zur herstellung von mikrokapseln, welche bromokriptinmesylat als pharmakologischen wirkstoff enthalten. CH666406A5 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB848405227A GB8405227D0 (en) 1984-02-29 1984-02-29 Bromocriptine compositions

Publications (1)

Publication Number Publication Date
CH666406A5 true CH666406A5 (de) 1988-07-29

Family

ID=10557324

Family Applications (2)

Application Number Title Priority Date Filing Date
CH6660/83A CH666406A5 (de) 1984-02-29 1983-12-14 Verfahren zur herstellung von mikrokapseln, welche bromokriptinmesylat als pharmakologischen wirkstoff enthalten.
CH830/85A CH667009A5 (de) 1984-02-29 1985-02-22 Bromocriptin enthaltende zusammensetzungen.

Family Applications After (1)

Application Number Title Priority Date Filing Date
CH830/85A CH667009A5 (de) 1984-02-29 1985-02-22 Bromocriptin enthaltende zusammensetzungen.

Country Status (26)

Country Link
JP (1) JPS60202812A (nl)
AT (1) AT387716B (nl)
AU (2) AU586621B2 (nl)
BE (1) BE901810A (nl)
CA (1) CA1256374A (nl)
CH (2) CH666406A5 (nl)
DE (1) DE3505743C2 (nl)
DK (1) DK175016B1 (nl)
ES (1) ES8705223A1 (nl)
FR (1) FR2560047B1 (nl)
GB (1) GB8405227D0 (nl)
GR (1) GR850506B (nl)
HK (1) HK85490A (nl)
HU (1) HU196121B (nl)
IE (1) IE58235B1 (nl)
IL (1) IL74459A (nl)
IT (1) IT1199948B (nl)
LU (1) LU85791A1 (nl)
MX (1) MX9203626A (nl)
NL (1) NL194231C (nl)
NZ (1) NZ211247A (nl)
PH (1) PH23266A (nl)
PT (1) PT80015B (nl)
SE (2) SE462259B (nl)
SG (1) SG69390G (nl)
ZA (1) ZA851546B (nl)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1992011000A1 (de) * 1990-12-22 1992-07-09 Schwarz Pharma Ag Verfahren zur herstellung wirkstoffhaltiger mikropartikel aus hydrolytisch abbaubaren polymeren
US5725841A (en) * 1993-03-17 1998-03-10 Minnesota Mining And Manufacturing Company Aerosol formulation containing an ester-, amide-, or mercaptoester-derived dispersing aid

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU4064285A (en) * 1984-03-21 1985-10-11 American Home Products Corporation Sustained release pharmaceutical capsules
DE3722383A1 (de) * 1986-07-14 1988-01-28 Sandoz Ag Neue verwendung von bromocriptin

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL265428A (nl) * 1960-06-06
CH507249A (de) * 1968-05-31 1971-05-15 Sandoz Ag Verfahren zur Herstellung von 2-Brom-a-ergokryptin
DE2553026A1 (de) * 1974-12-04 1976-06-10 Schlueter Edelfett Neue formulierungen
CH630257A5 (en) * 1975-03-17 1982-06-15 Hoffmann La Roche Sustained release formulation
IT1158162B (it) * 1977-12-22 1987-02-18 Sandoz Ag Composizioni farmaceutiche a base di derivati dell'ergolena e dell'ergolina
DE3045135A1 (de) * 1980-11-29 1982-06-09 Sandoz-Patent-GmbH, 7850 Lörrach Pharmazeutische kompositionen enthaltende bioabbaubare polymere
US4369172A (en) * 1981-12-18 1983-01-18 Forest Laboratories Inc. Prolonged release therapeutic compositions based on hydroxypropylmethylcellulose
DE3216870A1 (de) * 1982-05-03 1983-11-03 Schering AG, 1000 Berlin und 4709 Bergkamen Pharmazeutische zubereitungen mit zytostatischer wirkung
US4559222A (en) * 1983-05-04 1985-12-17 Alza Corporation Matrix composition for transdermal therapeutic system

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1992011000A1 (de) * 1990-12-22 1992-07-09 Schwarz Pharma Ag Verfahren zur herstellung wirkstoffhaltiger mikropartikel aus hydrolytisch abbaubaren polymeren
US5725841A (en) * 1993-03-17 1998-03-10 Minnesota Mining And Manufacturing Company Aerosol formulation containing an ester-, amide-, or mercaptoester-derived dispersing aid

Also Published As

Publication number Publication date
LU85791A1 (fr) 1985-12-11
CH667009A5 (de) 1988-09-15
HUT38254A (en) 1986-05-28
FR2560047A1 (fr) 1985-08-30
IT8547703A0 (it) 1985-02-20
JPS60202812A (ja) 1985-10-14
IL74459A0 (en) 1985-05-31
AU618599B2 (en) 1992-01-02
HU196121B (en) 1988-10-28
CA1256374A (en) 1989-06-27
AT387716B (de) 1989-03-10
DK86785D0 (da) 1985-02-26
PT80015B (pt) 1987-09-18
FR2560047B1 (fr) 1988-01-15
IL74459A (en) 1988-12-30
NL8500417A (nl) 1985-09-16
ZA851546B (en) 1986-10-29
AU3913685A (en) 1985-09-05
BE901810A (fr) 1985-08-26
DE3505743A1 (de) 1985-08-29
NZ211247A (en) 1989-02-24
ES540807A0 (es) 1987-05-01
AU586621B2 (en) 1989-07-20
NL194231C (nl) 2001-10-02
IE850495L (en) 1985-08-29
IE58235B1 (en) 1993-08-11
JPH0448776B2 (nl) 1992-08-07
ATA58085A (de) 1988-08-15
MX9203626A (es) 1992-09-01
AU3500689A (en) 1989-09-14
ES8705223A1 (es) 1987-05-01
SE8500961D0 (sv) 1985-02-27
PH23266A (en) 1989-06-23
PT80015A (pt) 1986-02-10
IT8547703A1 (it) 1986-08-20
DK86785A (da) 1985-08-30
HK85490A (en) 1990-10-25
IT1199948B (it) 1989-01-05
DK175016B1 (da) 2004-04-26
SG69390G (en) 1990-10-26
SE462259B (sv) 1990-05-28
GB8405227D0 (en) 1984-04-04
SE8500961L (sv) 1985-08-30
DE3505743C2 (de) 1995-02-16
GR850506B (nl) 1985-06-28
NL194231B (nl) 2001-06-01

Similar Documents

Publication Publication Date Title
DE3345314A1 (de) Oligomere hydroxycarbonsaeurederivate, deren herstellung und verwendung
CH671402A5 (nl)
DE3688213T2 (de) Polymer, seine herstellung und verwendung.
DE68910833T2 (de) Polylactid-zubereitungen.
DE3430852C2 (de) Neue Ester, deren Herstellung und Verwendung
DE602006000381T2 (de) Bioabsorbierbare pharmazeutische Zusammensetzung enthaltend einen PLGA-Copolymer
DE69129770T2 (de) Biologisch abbaubare hochmolekulare Polymere, ihre Herstellung und ihre Verwendung
AT408609B (de) Zubereitung zur stetigen und kontrollierten abgabe von medikamentösen substanzen und verfahren zu deren herstellung
DE69333817T2 (de) Leuprorelinpräparat mit verzögerter Wirkstoffabgabe
DE69727262T2 (de) Langsam freisetzende Zubereitung für bioaktive Substanz mit einer sauren Gruppe
CA1100041A (en) Absorbable pharmaceutical compositions based on isomorphic copolyoxalates
DE69434224T2 (de) Orales Verabreichungssystem für Desferrioxamin, Insulin und Cromolyn-Natrium
DE69232555T2 (de) Biologisch abbaubare Polymermischungen zur Arzneistoffabgabe
DE69838731T2 (de) Polyanhydride mit therapeutisch verwendbaren abbauprodukten
CH648048A5 (fr) Procede de preparation d'un copolymere d'acides lactique et glycolique.
HU186904B (en) Process for producing retarde pharmaceutical compositions
JPH0649185A (ja) 新規重合体
DE2842089A1 (de) Arzneimittel mit verzoegerter wirkstoffabgabe
US5187150A (en) Polyester-based composition for the controlled release of polypeptide medicinal substances
CH660488A5 (en) (Co)oligomeric hydroxycarboxylic acid derivatives, the preparation thereof, and the use thereof in pharmaceutical compositions
CH666406A5 (de) Verfahren zur herstellung von mikrokapseln, welche bromokriptinmesylat als pharmakologischen wirkstoff enthalten.
EP1152776B1 (de) Bioabbaubare, injizierbare oligomer-polymer-zusammensetzung
BE1001687A5 (fr) Composition a base de polyesters pour la liberation controlee de substances medicamenteuses.
EP0164571B1 (de) Retardformen des alpha-(2,5-Dimethoxy-phenyl)-beta-lycinamido-äthanols und Verfahren zu ihrer Herstellung
CH663718A5 (de) Pharmazeutische zusammensetzung enthaltend bromokryptin.

Legal Events

Date Code Title Description
PL Patent ceased